Epitomee Revenue and Competitors
Estimated Revenue & Valuation
- Epitomee's estimated annual revenue is currently $3.8M per year.
- Epitomee's estimated revenue per employee is $108,800
Employee Data
- Epitomee has 35 Employees.
- Epitomee grew their employee count by 13% last year.
Epitomee's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Finance | Reveal Email/Phone |
2 | Head Analytics and Biologics | Reveal Email/Phone |
3 | VP Business Development & Marketing | Reveal Email/Phone |
4 | VP R&D | Reveal Email/Phone |
5 | Senior Director Regulatory Affairs | Reveal Email/Phone |
6 | Data scientist | Reveal Email/Phone |
7 | Supply Chain Manager | Reveal Email/Phone |
8 | Process Development Engineer | Reveal Email/Phone |
9 | עובדת יצור | Reveal Email/Phone |
Epitomee Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.1M | 583 | 534% | N/A | N/A |
#2 | $1.6M | 53 | 212% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 65 | 27% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 469 | -3% | $2.3M | N/A |
#8 | $35.6M | 247 | 18% | N/A | N/A |
#9 | $38.3M | 277 | 23% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is Epitomee?
Epitomee is a privately held medical devices company developing ingestible devices to tackle some of today's most prevalent chronic diseases at their core with a self-managed, safe and effective way. Epitomee has developed, and commercializing drug-free self-administered capsules, aimed to prevent diabetes and address overweight & obesity co-morbidities by promoting weight loss and establishing a healthier lifestyle.
keywords:N/AN/A
Total Funding
35
Number of Employees
$3.8M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12.3M | 40 | 0% | N/A |
#2 | $2.2M | 62 | 226% | N/A |
#3 | $15.8M | 63 | 3% | N/A |
#4 | $28.6M | 66 | 6% | N/A |
#5 | $13.5M | 68 | 24% | N/A |